共 50 条
- [31] THE ERYTHROPOIETIC EFFECTS OF 6-KETO-PGE1 AND PGI2 CLINICAL RESEARCH, 1981, 29 (05): : A829 - A829
- [33] EFFECTS OF 6-KETO-PROSTAGLANDIN-E1 ON PERINATAL PULMONARY VASCULAR-RESISTANCE PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1981, 166 (01): : 148 - 152
- [34] THE EFFECTS OF PROSTACYCLIN (PGI2) AND 6-KETO-PGF1-ALPHA ON BOVINE PLASMA PROGESTERONE AND LH CONCENTRATIONS PROSTAGLANDINS, 1980, 20 (04): : 641 - 647
- [36] 6-KETO-PROSTAGLANDIN-E1 IS MORE POTENT THAN PROSTAGLANDIN-I2 AS A RENAL VASODILATOR AND RENIN SECRETAGOGUE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1981, 216 (01): : 24 - 27
- [37] HUMAN-PLATELET RICH PLASMA AND HUMAN-SERUM PROTECTS FROM INACTIVATION THE ANTI-AGGREGATORY CAPACITY OF PROSTACYCLIN-LIKE MATERIAL (PGI2) PRODUCED BY THE RAT STOMACH FUNDUS PROSTAGLANDINS, 1980, 19 (06): : 899 - 905
- [39] PROSTAGLANDIN-INDUCED MESENTERIC VASODILATION - TOLERANCE TO PGE2 BUT NOT PGI2 OR 6-KETO-PGE1 BLOOD VESSELS, 1980, 17 (03): : 150 - 150
- [40] STUDIES OF THE MECHANISMS INVOLVED IN THE FATE OF PROSTACYCLIN (PGI2) AND 6-KETO-PGF 1-ALPHA IN THE PULMONARY CIRCULATION PROSTAGLANDINS, 1978, 16 (06): : 871 - 884